Stonepine Capital Management, LLC URGN Holdings History
Stonepine Capital Management, LLC's UroGen Pharma Ltd Holding Summary
As of 2025-03-31, Stonepine Capital Management, LLC held 333,400.00 shares of UroGen Pharma Ltd(URGN), totaling $3.69 Mil. This investment constitutes 3.59% of their stock portfolio, and Stonepine Capital Management, LLC now holds 0.72% of the outstanding UroGen Pharma Ltd(URGN) stock.
The initial trade took place in 2022Q1. And since then Stonepine Capital Management, LLC has made 7 purchases of URGN, at an average price of $8.85, for a total of 1.64 Mil shares. In addition, there have been 3 sales at an average price of $11.90 for 1.30 Mil shares. Based on historical transaction data and URGN's current price of $14.04, Stonepine Capital Management, LLC's estimated gain on his URGN holdings is $5.71 Mil, reflecting a 39.35% gain to date.
Stonepine Capital Management, LLC URGN ($14.04) Holding Chart
Stonepine Capital Management, LLC URGN ($14.04) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
